ClinicalTrials.gg
Drug

Nitisinone clinical trials

Also written Orfadin.

studies test it
14
open now
0
in phase 3
3
first study started
2005

How each study uses nitisinone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
18 Jan 2002 · ORFADIN · NDA 021232 (FDA, Drugs@FDA)
European Union
21 Feb 2005 · Orfadin · EMEA/H/C/000555 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nitisinone
10

Brand

Orfadin
7

Other names

NTBC
1

Studies by the year they started

14 studies that test it; most in 2013 (3)

Studies that test nitisinone, by start year
YearStudies
20051
20111
20122
20133
20142
20152
20161
20171
20191

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
4
Phase 3
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 5

Swedish Orphan Biovitrum (5) · Cycle Pharmaceuticals Ltd. (3) · University of Liverpool (2) · National Human Genome Research Institute (NHGRI) (1) · University of California, San Diego (1) · National Eye Institute (NEI) (1) · Sutphin Drugs (1)

Often tested with

Tested in the same studies.

Tolbutamide (1) · Metoprolol (1) · Chlorzoxazone (1) · Furosemide (1)

Studies

Open first, then newest update. How each study uses nitisinone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call nitisinone · ClinicalTrials.gg INT003664

  • MeSH (NLM) C077073nitisinoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) K5BN214699NITISINONEConfirmed FDA, NLM, Wikidata
  • RxNorm 61805Confirmed FDA, Wikidata
  • Wikidata Q3877355nitisinoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61862NitisinoneOne source FDA
  • DrugBank DB00348One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.